Long-Term Efficacy of a Hepatitis E Vaccine

Zhang, Jun; Zhang, Xuefeng; Huang, Shoujie; Wu, Ting; Hu, Yuemei; Wang, Zhongze; Wang, Hua; Jiang, Han-Min; Wang, Yijun; Yan, Qiang; Guo, Meng; Liu, Xiaohui; Li, Jingxin; Yang, Changlin; Tang, Quan; Jiang, Renjie; Pan, Huirong; Li, Yimin; Wai‐Kuo Shih, J.; Ng, Mun‐Hon; Zhu, Fengcai; Xia, Ningshao

doi:10.1056/nejmoa1406011

Public

Long-Term Efficacy of a Hepatitis E Vaccine

Published in New England Journal of Medicine • Mar 4, 2015

Authors:

Jun Zhang

Xuefeng Zhang

Shoujie Huang

Abstract

BACKGROUND: Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined. METHODS: In an initial efficacy study, we randomly assigned healthy adults 16 to 65 years of age to receive three doses of either a hepatitis E vaccine (...

Subject

Medicine

Hepatitis A vaccine

Term (time)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!